| Primary cutaneous mucormycosis caused by Rhizomucor variabilis in an immunocompetent patient. | |
| | |
MedLine Citation:
|
PMID: 19562506 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Primary cutaneous mucormycosis is an uncommon disease and occurs mainly in patients with immunocompromised disorders. We report a case of cutaneous mucormycosis in an immunocompetent man in whom no definite precipitating factors were noted. The isolate was identified as Rhizomucor variabilis according to the fungus morphology and DNA sequencing results. The lesion was successfully treated with oral Itraconazole, although the in vitro drug-susceptibility test showed resistance. |
| | |
Authors:
|
Ying Zhao; Qiangqiang Zhang; Li Li; Junhao Zhu; Kefei Kang; Lianjun Chen |
Related Documents
:
|
3170386 - Survival of staphylococcus epidermidis on the skin of patients of lepromatous leprosy. 6226496 - Incidence of common dermatoses in a predominantly black dermatologic practice. 20428906 - Abnormal overexpression of mastocytes in skin biopsies of fibromyalgia patients. 2535016 - Drug eruptions (a series of 148 cases). 19473626 - Paricalcitol and outcome: a manual on how a vitamin d receptor activator (vdra) can hel... 23456496 - Cholecystectomy and clinical presentations of gastroparesis. |
Publication Detail:
|
Type: Case Reports; Journal Article Date: 2009-06-27 |
Journal Detail:
|
Title: Mycopathologia Volume: 168 ISSN: 1573-0832 ISO Abbreviation: Mycopathologia Publication Date: 2009 Nov |
Date Detail:
|
Created Date: 2009-10-13 Completed Date: 2009-12-22 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 7505689 Medline TA: Mycopathologia Country: Netherlands |
Other Details:
|
Languages: eng Pagination: 243-7 Citation Subset: IM |
Affiliation:
|
Department of Dermatology, Huashan Hospital, Fudan University, 200040, Shanghai, China. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Antifungal Agents
/
therapeutic use Humans Immunocompetence* Itraconazole / therapeutic use Male Middle Aged Mucormycosis / drug therapy, microbiology* Rhizomucor / physiology* |
| Chemical | |
Reg. No./Substance:
|
0/Antifungal Agents; 84625-61-6/Itraconazole |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Long-term neurodevelopmental effects of early detection and treatment in a 6-year-old patient with a...
Next Document: Molecular cloning, sequence and expression analysis of ZmArf2, a maize ADP-ribosylation factor.